Izervay is a prescription medication specifically designed to treat geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD). GA leads to the progressive degeneration of the retina, resulting in significant vision loss over time. Izervay’s primary function is to slow this debilitating condition’s progression, thereby helping preserve vision for a longer period.
Mechanism Of Action
The progression of GA is closely linked to the overactivation of the complement system, a component of the immune response. Izervay contains avacincaptad pegol, a pegylated RNA aptamer specifically targeting the complement protein C5. By inhibiting C5, Izervay aims to prevent the formation of the membrane attack complex (MAC), which is responsible for initiating retinal cell death. This targeted approach helps reduce retinal cell loss and inflammation, thereby slowing the progression of GA.
Administration
Izervay is administered through intravitreal injections, which are injected directly into the eye. The recommended dosing schedule is one injection per month. These injections must be performed by a qualified healthcare professional in a clinical setting to ensure proper aseptic technique and to minimize potential risks associated with the procedure.
Efficacy
Clinical trials have demonstrated that Izervay can slow the progression of GA. In studies where patients received monthly injections over a year, the drug was shown to reduce the development of GA by approximately 14% to 20%. It’s important to note that while Izervay slows disease progression, it does not reverse existing retinal damage or restore lost vision.
Side Effects And Risks
Like all medical treatments, Izervay carries potential side effects and risks. Common side effects include blood in the white of the eye, increased intraocular pressure, blurred vision, and the development of wet AMD. More serious complications, such as endophthalmitis (an eye infection) and retinal detachment, can occur. Patients are advised to contact their healthcare provider immediately if they experience symptoms like eye redness, pain, increased discomfort, worsening vision, an increased number of floaters, flashes of light, or heightened sensitivity to light.
Considerations And Monitoring
Before initiating treatment with Izervay, patients must discuss their full medical history with their healthcare provider, including any history of eye infections, inflammation, flashes of light, floaters, high intraocular pressure, or glaucoma. Pregnant or breastfeeding individuals should consult their doctor to understand potential risks. Regular monitoring by an eye care professional is essential during the treatment course to promptly identify and manage any adverse effects or complications.
How Can We Help?
Izervay represents a significant advancement in the management of geographic atrophy secondary to age-related macular degeneration. Meeting with a California Izervay retina specialist can help determine whether Izervay is an appropriate treatment option for you. Call Retina Associates of Orange County today to schedule an appointment.
